Dr Daniel Krell

Professional statement

Dr Daniel Krell is a highly regarded oncology consultant. He specialises in gastrointestinal, colorectal, pancreatic, hepatic, and biliary duct cancers, as well as neuroendocrine tumours. He possesses extensive expertise in employing chemotherapy, targeted therapy, and immunotherapy. Dr Krell also oversees patients with cancer of an undisclosed origin and leads in a clinical capacity in this domain.

Within the Royal Free Trust, he collaborates as a member of the multidisciplinary team handling gastro-oesophageal and hepatobiliary cancer cases. Moreover, he serves as the clinical head for neuroendocrine tumour oncology at The Royal Free Hospital.

He underwent his oncology training at University College and the Royal Free Hospitals in London. In addition to his primary medical degree, he achieved a bachelor's degree in immunology and microbiology, alongside a DPhil in clinical medicine at the University of Oxford's Welcome Trust Centre for Human Genetics. The funding for his research came from Cancer Research UK and HCA. His study focused on constructing models to explore the influence of genetic mutations in genes controlling cellular metabolism on cancer development, with potential implications for the identification of novel therapeutic targets in this field.

Dr Krell continues to be actively involved in clinical research and trials aimed at discovering groundbreaking cancer therapies, with a specific focus on gastrointestinal, hepatobiliary, and neuroendocrine tumours. He has written several peer-reviewed papers and presented his findings at national and international conferences.